Edgar G. Engleman

Stanford University

NIH Rank #5723
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#5,723
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 5 grants · National rank #5723.

Top grants by award amount

Edgar G. Engleman's NIH grant portfolio, ranked by award amount.

  • 5R01CA262361-04R01
    Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
    $690.6K
    award amount
  • 5R01CA251174-04R01
    Targeting Lymph Node Dependent Immune Tolerance in Cancer
    $515K
    award amount
  • 5P01CA244114-04P01
    Pancreatic Cancer Development: Genetic and Immune Regulation
    $323.3K
    award amount
  • 5U54CA274511-02U54
    Systems Biology of Tumor-Immune-Stromal Interactions in Metastatic Progression
    $293.7K
    award amount
  • 3R01CA233958-05S1R01
    Effects of FLASH Radiation on Cancer and the Immune Response
    $104.5K
    award amount

Affiliation

Institutions that have administered grants for Edgar G. Engleman.

Affiliated with Stanford University (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Stanford University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5723